TABLE 3.
Effect of RHT and EIA on LPFS, DFS, and OS
| EIA + RHT (95% CI) | EIA (95% CI) | HR (95% CI) | P* | |
|---|---|---|---|---|
| LPFS | ||||
| Median duration, yr | 8.3 (3.0 to >12.0) | 2.5 (1.7–6.3) | 0.63 (0.40–0.99) | 0.044 |
| 3 yrs (%) | 63 (52–74) | 49 (37–60) | ||
| 5 yrs (%) | 56 (44–68) | 45 (33–57) | ||
| Disease-free survival | ||||
| Median duration, yr | 2.7 (1.7–4.0) | 1.5 (1.1–2.2) | 0.72 (0.49–1.05) | 0.040 |
| 3 yrs (%) | 46 (34–57) | 31 (21–42) | ||
| 5 yrs (%) | 34 (23–45) | 27 (16–37) | ||
| OS | ||||
| No. deaths | 40 | 44 | 0.82 (0.53–1.26) | 0.5932 |
| Median duration, yr | 6.8 (3.8 to >12.0) | 6.2 (2.8–8.2) | ||
| 3 yrs (%) | 65 (54–76) | 61 (50–72) | ||
| 5 yrs (%) | 57 (45–68) | 55 (43–67) |
Log-rank test.